DateMay 27 2021 Expired!
Time3:00 pm - 4:00 pm
Share this event
About the Webinar
This webinar is to introduce Nexodyn’s efficacy of Hypochlorus Acidoxidizing solution in treating stalled wounds.
Prof. Dr. Harikrishna K.R.Nair S.I.S Kmn
MD, FRCPI FCWCS OSH (NIOSH), OHD (DOH), CMIA (MAL) CHM (USA) ESWT (Austria, Germany) FMSWCP, PG in Wound Healing and Tissue Repair (Cardiff, UK) ICW Chairman Wounds Malaysia Head and Consultant Wound Care Unit, Dept. of Internal Medicine, KLH Founding President, Malaysian Society of Wound Care Professionals,
Professor Dr. Harikrishna K.R.Nair, the founding President of the Malaysian Society of Wound Care Professionals (MSWCP) and the Head of the Wound Care Unit, Department of Internal Medicine, Hospital Kuala Lumpur was awarded the gold medal for his contribution in education by the Journal of Wound Care (JWC) World Union of Wound Healing Societies (WUWHS) in an live international award ceremony from the United Kingdom. Professor Hari has been instrumental in setting up the post basic in wound management under the Ministry of Health Malaysia and the Certificate in Clinical Wound Care under the Asian Wound Care Association.
He has also conducted many courses, workshops and conferences across Asia such as in the ASEAN countries and Maldives. He has also edited and authored 19 books and numerous journals and presentations. This award is a great recognition of his work in the field of education especially in the management of chronic wounds such as Diabetic foot ulcers, venous ulcers, pressure injuries and other chronic complex wounds. He is the first Malaysian to receive this prestigious international award. Congratulations to Professor Harikrishna for putting Malaysia on the global map.
Missed out on our Webinar “Nexodyn: The efficacy of Hypochlorus Acidoxidizing Solution in Treating Stalled Wounds”, not to worry catch the whole session over here.
Ms Patrizia Marzorati. PhD
Head of Medical Affairs- APR Applied Pharma Research
Patrizia Marzorati started her career in the Swiss based company Applied Pharma Research (APR) in 2010 after obtaining, with full marks, a degree in Medical Biotechnology and a PhD in Cellular and Molecular Biology in Milan university. Also council member of Board of Directors at IRCCS Hospital Ca’ Granda Milano from 2018, after covering different key positions she is now the head of medical affair, and she plays a significant role in medical research or product development for advanced scientific solutions as Nexodyn.